buserelin has been researched along with nafarelin in 45 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (22.22) | 18.7374 |
| 1990's | 21 (46.67) | 18.2507 |
| 2000's | 11 (24.44) | 29.6817 |
| 2010's | 3 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuyama, A; Minaguchi, H; Shirasu, K; Uemura, T; Yanagisawa, T | 1 |
| Doesburg, WH; Franssen, AM; Rolland, R; Thomas, CM; van der Heijden, PF; Willemsen, WN | 1 |
| Moghissi, KS | 1 |
| Schenken, RS | 1 |
| Ding, YQ; Huhtaniemi, I; Jaakkola, T; Kellokumpu-Lehtinen, P; Martikainen, H; Rönnberg, L; Tapanainen, J; Valavaara, R | 1 |
| Bianchi, C; Bocciolone, L; Candiani, GB; Fedele, L; Vercellini, P | 1 |
| Erickson, LD; Ory, SJ | 1 |
| Shaw, RW | 3 |
| Lemay, A | 1 |
| Nillius, SJ | 1 |
| Eisenberger, MA; Friedman, MA; O'Dwyer, PJ | 1 |
| Nillius, SJ; Rojanasakul, A | 1 |
| Abyholm, T; Henriksen, T; Magnus, O; Tanbo, T | 1 |
| Besanko, M; Healy, D; MacLachlan, V; Morrow, L; O'Shea, F; Trounson, A; Wade, H | 1 |
| Barlow, DH; Lockwood, GM; Pinkerton, SM | 1 |
| Van Leusden, HA | 1 |
| Garoff, L; Hillensjö, T; Hultling, C; Levi, R; Nylund, L; Rosenborg, L; Sjöblom, P | 1 |
| Ashkenazi, J; Dicker, D; Feldberg, D; Goldman, JA; Voliowich, I | 1 |
| Barnes, KM; Cutler, GB; Hill, S; Jones, J; Manasco, PK; Oerter, KE | 1 |
| Shaw, RW; Waller, KG | 1 |
| Amit, S; Avrech, OM; Fisch, B; Goldman, GA; Neri, A; Ovadia, J; Pinkas, H; Zukerman, Z | 1 |
| Bühler, K; Gärtner, A; Kuhlmann, M; Regidor, PA; Schindler, AE; Schindler, EM | 1 |
| Minaguchi, H; Taga, M | 1 |
| Barash, A; Ben-Arie, A; Manor, M; Milman, D; Shoham, Z; Weissman, A | 1 |
| Husa, LM; Simberg, N; Tiitinen, A; Tulppala, M | 1 |
| Avery, S; Brinsden, P; Lass, A; Peat, D | 1 |
| Baillie, HS; Dada, T; Salha, O; Sharma, V | 1 |
| Eldar-Geva, T; Garcia-Velasco, JA; Healy, DL; Leader, A; Lindenberg, S; Mikkelsen, AL; Out, HJ; Pellicer, A; Rodriguez-Escudero, FJ | 1 |
| Barash, A; Weissman, A | 1 |
| Famelos, M; Gabbe, M; Healy, D; Kovacs, G; Platteau, P | 1 |
| Ogita, S; Tanaka, T; Umesaki, N | 1 |
| Emperaire, JC; Parneix, I; Parneix, P; Ruffie, A | 1 |
| Fang, F; Huang, M | 1 |
| Allgar, V; Dada, T; Salha, O; Sharma, V | 1 |
| Minoura, H; Noritaka, F; Shibahara, T; Takeuchi, S; Toyoda, N; Tsuiki, Y | 1 |
| Al-Mizyen, E; Al-Shawaf, T; Bhide, M; El-Nemr, A; Gillott, C; Grudzinskas, JG; Khalifa, Y; Lower, AM | 1 |
| Fujimoto, S; Hareyama, H; Hoshi, N; Kataoka, S; Kudo, M; Sakuragi, N; Yamada, H | 1 |
| Kinoshita, K; Seko, M; Takeuchi, H; Tokita, A | 1 |
| Harada, T | 1 |
| Kojima, R; Nakagawa, K; Saito, H; Takahashi, Y | 1 |
| Campbell, B; Hopkisson, J; Jayaprakasan, K; Johnson, I; Raine-Fenning, N; Thornton, J | 1 |
| Berglund, L; Hadziosmanovic, N; Holte, J; Huber, M | 1 |
10 review(s) available for buserelin and nafarelin
| Article | Year |
|---|---|
Hormonal therapy before surgical treatment for uterine leiomyomas.
Topics: Antineoplastic Agents; Buserelin; Combined Modality Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Hysterectomy; Leiomyoma; Leuprolide; Nafarelin; Premedication; Uterine Neoplasms | 1991 |
GnRH analogues in the treatment of endometriosis.
Topics: Buserelin; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Nafarelin; Pituitary Hormone-Releasing Hormones | 1989 |
Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma.
Topics: Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Goserelin; Humans; Leuprolide; Male; Nafarelin; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
Luteinizing-hormone-releasing hormone agonist treatment in patients with previously failed folliculogenesis during in vitro fertilization therapy.
Topics: Buserelin; Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Menstrual Cycle; Nafarelin; Ovarian Follicle; Ovulation | 1988 |
Impact of different GnRH analogs in benign gynecological disorders related to their chemical structure, delivery systems and dose.
Topics: Buserelin; Dose-Response Relationship, Drug; Drug Delivery Systems; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Leuprolide; Menstrual Cycle; Nafarelin; Structure-Activity Relationship; Triptorelin Pamoate | 1994 |
Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty.
Topics: Adult; Age Determination by Skeleton; Age Factors; Body Height; Buserelin; Child; Clinical Trials as Topic; Female; Gonadotropin-Releasing Hormone; Humans; Male; Nafarelin; Prognosis; Puberty, Precocious; Triptorelin Pamoate | 1993 |
Should we still advise infertile couples to use (barrier) contraception before IVF down-regulation?
Topics: Buserelin; Down-Regulation; Female; Fertility Agents, Female; Fertilization in Vitro; Humans; Infertility; Leuprolide; Male; Nafarelin; Outcome Assessment, Health Care; Pregnancy; Retrospective Studies | 2000 |
[Prevention and therapy of side effects of gonadotropin-releasing hormone agonist in patients with endometriosis].
Topics: Buserelin; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Nafarelin; Osteoporosis | 1999 |
[Endometriosis].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Buserelin; Combined Modality Therapy; Danazol; Drug Therapy, Combination; Endometriosis; Estrogens; Evidence-Based Medicine; Female; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Nafarelin | 2006 |
[In vitro fertilization and embryo transfer].
Topics: Administration, Intranasal; Buserelin; Drug Therapy, Combination; Embryo Transfer; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Menotropins; Nafarelin; Ovulation Induction | 2006 |
13 trial(s) available for buserelin and nafarelin
| Article | Year |
|---|---|
On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol.
Topics: Antigens, Tumor-Associated, Carbohydrate; Buserelin; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Menstrual Cycle; Nafarelin; Osmolar Concentration; Retrospective Studies; Tissue Adhesions | 1992 |
Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostatic carcinoma.
Topics: Buserelin; Clinical Trials as Topic; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Gonadotropins, Pituitary; Goserelin; Humans; Leuprolide; Male; Nafarelin; Neoplasms, Hormone-Dependent; Orchiectomy; Prostatic Neoplasms; Testosterone | 1986 |
A prospective randomized single-blind comparative trial of nafarelin acetate with buserelin in long-protocol gonadotrophin-releasing hormone analogue controlled in-vitro fertilization cycles.
Topics: Administration, Intranasal; Adult; Buserelin; Embryo Transfer; Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Menotropins; Nafarelin; Pituitary Gland; Pregnancy; Pregnancy, Multiple; Prospective Studies; Single-Blind Method | 1995 |
Assisted ejaculation combined with in vitro fertilisation: an effective technique treating male infertility due to spinal cord injury.
Topics: Adult; Buserelin; Ejaculation; Female; Fertilization in Vitro; Humans; Infertility, Male; Male; Middle Aged; Nafarelin; Physical Stimulation; Physostigmine; Pregnancy; Spinal Cord Injuries; Vibration | 1994 |
A prospective randomized comparison of two gonadotrophin-releasing hormone agonists, nafarelin acetate and buserelin acetate, in in-vitro fertilization-embryo transfer.
Topics: Administration, Intranasal; Adult; Buserelin; Embryo Transfer; Female; Fertilization in Vitro; Humans; Nafarelin; Ovulation Induction; Prospective Studies | 1994 |
Gonadotropin-releasing hormone analogues for the treatment of endometriosis: long-term follow-up.
Topics: Adolescent; Adult; Buserelin; Endometriosis; Female; Follow-Up Studies; Goserelin; Humans; Middle Aged; Nafarelin; Prospective Studies; Recurrence | 1993 |
Intranasal nafarelin versus buserelin (short protocol) for controlled ovarian hyperstimulation before in vitro fertilization: a prospective clinical trial.
Topics: Administration, Intranasal; Adult; Buserelin; Chorionic Gonadotropin; Cross-Over Studies; Estradiol; Female; Fertilization in Vitro; Humans; Menotropins; Nafarelin; Ovulation Induction; Progesterone; Prospective Studies | 1996 |
Comparison of buserelin and nafarelin in IVF cycles and in subsequent frozen-thawed embryo transfer cycles.
Topics: Adult; Buserelin; Embryo Transfer; Female; Fertility Agents, Female; Fertilization in Vitro; Hormones; Humans; Nafarelin; Pregnancy; Superovulation | 1998 |
A comparison of three gonadotrophin-releasing hormone analogues in an in-vitro fertilization programme: a prospective randomized study.
Topics: Administration, Inhalation; Adult; Buserelin; Delayed-Action Preparations; Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hormones; Humans; Injections, Subcutaneous; Leuprolide; Nafarelin; Pregnancy; Pregnancy Rate; Prospective Studies | 1999 |
A prospective, randomized, double-blind clinical trial to study the efficacy and efficiency of a fixed dose of recombinant follicle stimulating hormone (Puregon) in women undergoing ovarian stimulation.
Topics: Buserelin; Chorionic Gonadotropin; Double-Blind Method; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Follicle Stimulating Hormone, Human; Humans; Leuprolide; Microinjections; Nafarelin; Ovulation Induction; Pregnancy; Progesterone; Prospective Studies; Recombinant Proteins | 1999 |
A prospective randomized comparison of routine buserelin acetate and a decreasing dosage of nafarelin acetate with a low-dose gonadotropin-releasing hormone agonist protocol for in vitro fertilization and intracytoplasmic sperm injection.
Topics: Abortion, Spontaneous; Adult; Buserelin; Chorionic Gonadotropin; Embryo Implantation; Embryo Transfer; Endometrium; Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Follicle Stimulating Hormone; Hormones; Humans; Luteinizing Hormone; Male; Nafarelin; Pregnancy; Progesterone; Prospective Studies; Sperm Injections, Intracytoplasmic; Time Factors | 2001 |
Clinical evaluation of three different gonadotrophin-releasing hormone analogues in an IVF programme: a prospective study.
Topics: Administration, Intranasal; Adult; Buserelin; Embryo Transfer; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Menotropins; Nafarelin; Oocytes; Ovulation Induction; Pregnancy; Pregnancy Rate; Prospective Studies; Treatment Outcome | 2002 |
A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count.
Topics: Adult; Buserelin; Female; Fertility Agents, Female; Fertilization in Vitro; Follicle Stimulating Hormone, Human; Humans; Nafarelin; Oocyte Retrieval; Oocytes; Ovarian Follicle; Ovulation Induction; Pregnancy; Pregnancy Outcome; Prospective Studies; Treatment Outcome | 2010 |
23 other study(ies) available for buserelin and nafarelin
| Article | Year |
|---|---|
Mechanisms involved in the pituitary desensitization induced by gonadotropin-releasing hormone agonists.
Topics: Animals; Buserelin; Cells, Cultured; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Leuprolide; Luteinizing Hormone; Male; Nafarelin; Pituitary Gland; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, LHRH; RNA, Messenger | 1992 |
Gonadotropin-releasing hormone analogs in the treatment of endometriomas.
Topics: Buserelin; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Nafarelin | 1990 |
The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with increased and decreased gonadotropin secretion: reevaluation by a highly sensitive immunometric assay.
Topics: Adult; Aged; Biological Assay; Buserelin; Endometriosis; Female; Fluorescent Antibody Technique; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Menopause; Middle Aged; Nafarelin; Orchiectomy; Ovarian Neoplasms; Ovariectomy; Prostatic Neoplasms; Radioimmunoassay; Uterine Neoplasms | 1990 |
Medical treatment of mild endometriosis in infertile women: analysis of a failure.
Topics: Buserelin; Danazol; Endometriosis; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Nafarelin | 1990 |
Rationale in use of LHRH analogues in endometriosis.
Topics: Buserelin; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Nafarelin | 1989 |
Mechanism of LHRH analogue action in uterine fibroids.
Topics: Buserelin; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Nafarelin; Uterine Neoplasms | 1989 |
Clinical appreciation of LHRH analogue formulations.
Topics: Buserelin; Delayed-Action Preparations; Endometriosis; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Nafarelin; Triptorelin Pamoate | 1989 |
Gonadotropin releasing hormone analogs for female contraception by inhibition of ovulation.
Topics: Administration, Intranasal; Adult; Buserelin; Contraceptive Agents, Female; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Nafarelin; Ovulation; Progesterone; Time Factors | 1985 |
Luteinizing hormone releasing hormone (LHRH): II. A new contraceptive agent.
Topics: Buserelin; Contraceptive Agents; Female; Gonadotropin-Releasing Hormone; Humans; Male; Nafarelin; Pregnancy | 1986 |
[Gonadotropin releasing hormone agonists. A new therapeutic principle in gynecology].
Topics: Buserelin; Female; Genital Diseases, Female; Gonadotropin-Releasing Hormone; Humans; Nafarelin; Pituitary Hormone-Releasing Hormones | 1988 |
GnRH agonists-antagonists--clinical applications.
Topics: Buserelin; Danazol; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leiomyoma; Nafarelin; Osteolysis; Polycystic Ovary Syndrome; Uterine Neoplasms | 1988 |
Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy.
Topics: Administration, Intranasal; Adult; Antineoplastic Agents, Hormonal; Buserelin; Chemotherapy, Adjuvant; Female; Gonadotropin-Releasing Hormone; Goserelin; Hormones; Humans; Infertility, Female; Injections, Intramuscular; Leiomyoma; Leuprolide; Nafarelin; Pregnancy; Pregnancy Rate; Retrospective Studies; Time Factors; Triptorelin Pamoate; Uterine Neoplasms | 1997 |
Change in C-terminal cross-linking domain of type I collagen in urine, a new marker of bone resorption, during and after gonadotropin-releasing hormone agonist administration.
Topics: Adult; Amino Acids; Antineoplastic Agents, Hormonal; Biomarkers; Bone Density; Bone Resorption; Buserelin; Collagen; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Leiomyoma; Middle Aged; Nafarelin; Uterine Neoplasms | 1997 |
Prospective evaluation of endometrial thickness as a predictor of pituitary down-regulation after gonadotropin-releasing hormone analogue administration in an in vitro fertilization program.
Topics: Adult; Buserelin; Endometrium; Estradiol; Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Nafarelin; Pituitary Gland; Prospective Studies; Sensitivity and Specificity; Triptorelin Pamoate; Ultrasonography | 1998 |
Histological evaluation of endometrium on the day of oocyte retrieval after gonadotrophin-releasing hormone agonist-follicle stimulating hormone ovulation induction for in-vitro fertilization.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Endometrium; Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Nafarelin; Oocytes; Ovulation Induction; Progesterone | 1998 |
A comparison of three GnRH analogues in an IVF programme.
Topics: Buserelin; Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Hormones; Humans; Leuprolide; Nafarelin; Ovary; Pituitary Gland; Time Factors | 2000 |
Altered sensitivity to anti-endometriosis medicines in an adenomyosis patient with thyroid dysfunction.
Topics: Adult; Buserelin; CA-125 Antigen; Cinnamomum zeylanicum; Danazol; Endometriosis; Estrogen Antagonists; Female; Hormones; Humans; Hyperthyroidism; Japan; Leuprolide; Magnoliopsida; Medicine, East Asian Traditional; Nafarelin; Phytotherapy; Plant Extracts; Thyrotropin; Thyroxine; Triiodothyronine | 2000 |
[Comparison of different protocols of ovulation induction, by GnRH agonists and chorionic gonadotropin].
Topics: Adult; Buserelin; Chorionic Gonadotropin; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteal Phase; Luteinizing Hormone; Nafarelin; Ovulation Induction; Pregnancy; Triptorelin Pamoate | 2001 |
Utero-ovarian blood flow characteristics of pituitary desensitization.
Topics: Adult; Aging; Arteries; Blood Flow Velocity; Buserelin; Embryo Transfer; Endometrium; Estradiol; Female; Fertilization in Vitro; Follicular Phase; Gonadotropin-Releasing Hormone; Humans; Longitudinal Studies; Nafarelin; Oocyte Donation; Ovarian Cysts; Ovary; Pituitary Gland; Prospective Studies; Pulsatile Flow; ROC Curve; Ultrasonography, Doppler, Color; Ultrasonography, Doppler, Pulsed; Uterus; Vascular Resistance | 2001 |
Cytogenetic analysis of uterine leiomyoma: the size, histopathology and GnRHa-response in relation to chromosome karyotype.
Topics: Adult; Buserelin; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 7; Female; Gonadotropin-Releasing Hormone; Humans; Karyotyping; Leiomyoma; Leuprolide; Magnetic Resonance Imaging; Middle Aged; Nafarelin; Uterine Neoplasms | 2003 |
Association of bone mineral density with vitamin D and estrogen receptor gene polymorphisms during GnRH agonist treatment.
Topics: Adult; Biomarkers; Bone Density; Bone Remodeling; Buserelin; Female; Gonadotropin-Releasing Hormone; Haplotypes; Humans; Leuprolide; Nafarelin; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Receptors, Calcitriol; Receptors, Estrogen | 2004 |
Using the ovarian sensitivity index to define poor, normal, and high response after controlled ovarian hyperstimulation in the long gonadotropin-releasing hormone-agonist protocol: suggestions for a new principle to solve an old problem.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Cross-Sectional Studies; Drug Administration Schedule; Drug Therapy, Combination; Female; Fertility Agents, Female; Fertilization in Vitro; Follicle Stimulating Hormone, Human; Gonadotropin-Releasing Hormone; Humans; Live Birth; Logistic Models; Nafarelin; Nomograms; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovary; Ovulation; Ovulation Induction; Pregnancy; Pregnancy Rate; Recombinant Proteins; Retrospective Studies; Risk Factors; Treatment Outcome | 2013 |
INN Common stem: -relin.
Topics: Antineoplastic Agents, Hormonal; Buserelin; Fertility Agents, Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Nafarelin; Terminology as Topic; Triptorelin Pamoate | 2017 |